Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 trial update for JointStem in degenerative arthritis of the knee (osteoarthritis) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Arthritis
• Knee Osteoarthritis

Drugs mentioned

• JointStem

Snippet

Sponsor: R-Bio | Conditions: Degenerative Arthritis, Knee Osteoarthritis | Phase 3 | Status: COMPLETED